Wednesday, April 22, 2015

Alzheimer's Research

About a month ago I had a phone call from the McCusker Alzheimer’s Research Foundation of Western Australia.  The caller asked if I was interested in joining a clinical trial of a drug which is used to delay the clinical symptoms of Alzheimers Disease.  The study will run for a minimum of 4 years. I agreed to talking about the trial at a later date and had a follow-up phone call from  the McClusker Foundation yesterday.

After a detailed explanation, I agreed to participate.    The trial goes something like this... an initial interview with a blood test and a couple of memory tests.  Sign the documents and start.    The name of the trial is long.

A Double Blind, Randomized, Placebo Controlled, Parallel Group Study to Simultaneously Qualify a Biomarker Algorithm for Prognosis of Risk of Developing Mild Cognative Impairment due to Alzheimer’s disease (MCE due to AD) and to Test the Safety and Efficacy of Pioglitazone to Delay the Onset of MCI due to AD in Cognitively Normal Subjects

Or as I read it, there are two groups, one taking a placebo and the other taking Pioglitazone. We are testing the safety and efficacy of the drug.   I already have symptoms of MCI (mild cognative impairment) I am losing names and my car keys.

I’ll let everyone know how things work out, if I remember.

No comments: